The Richard N. Merkin Prize in Biomedical Technology recognizes innovators whose pathbreaking technological developments are demonstrably improving human health. By concentrating on individuals and teams at the forefront of these advances, the prize will illuminate the important work taking place across multiple disciplines, and in doing so support and inspire continued innovation.
The Merkin Prize has an intentional focus on real-world impact, and a goal of shining a light on innovators themselves and how their work is transforming health care. It is administered by the Broad Institute of MIT and Harvard, one of the world’s leading biomedical research institutes. The new prize will annually celebrate a novel technology and recognize up to four key contributors, including individuals and teams, from anywhere in the world with a cash award of $400,000.